Kura Oncology, Inc. · 2 days ago
Regional Sales Director, Southeast
Maximize your interview chances
BiopharmaBiotechnology
Comp. & Benefits
Insider Connection @Kura Oncology, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Identify, recruit, hire, train, develop, motivate and retain top performing field sales personnel
Prepare field-level action plans and lead and manage the behaviors needed to support the successful execution of the plans
Field expert in market, competition, disease state, customer segments and commercial opportunity landscapes
Understand and interpret sales and data reports and apply proactively and reactively clear and specific direction to drive specific behaviors and sales performance
Establish and build key customer relationships to provide appropriate clinical and business support to drive area performance
Effectively, efficiently and appropriately triage internal and external customer needs, issues and request in order to lower or remove barriers to core success factors
Coach, teach and lead teams to engage customers in order to establish the foundation of disease awareness, appropriate patient profiles and compliant product utilization
Execute recurring field visits with field team and provide timely written and verbal feedback
Work with and partner with marketing, training, access and operations to deliver strategic imperatives while providing real-time feedback and suggestions on areas to continually improve organizational and operational excellence
Constantly evaluate all internal and external factors in order to provide suggestions and guidance on more effective ways to meet and exceed goals
Be the field facing lead for establishing the Kura Oncology name within the oncology-hematology community
Fiscal responsibility and budget management to achieve maximize sales results
Maintains highest level of compliance and ethics for self, team and organization
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration
10+ years of pharmaceutical/biotech commercial experience within the oncology/hematology and/or rare disease markets, with a minimum of 5 years of experience managing direct reports and leading teams in oncology and/or rare disease
Successful and documented track record of attracting, developing and retaining talent and building high performing teams
Strategic and analytical thinking as demonstrated by key projects/initiatives
Strong cross-functional leadership skills and ability to collaborate effectively within various groups
Managerial Courage
Excellent written and oral communication skills
Strong computer skills, notably WORD, EXCEL and POWER POINT
Preferred
Experience in pharmaceutical/biotech marketing, managed care/market access, commercial operations and/or sales training
Launch preparation and successful launch experience in oncology/hematology; rare disease experience
Benefits
Career advancement/ development opportunities
Competitive comp package
Bonus
401K + Employer contributions
Generous stock options
ESPP Plan
20 days of PTO to start
18 Holidays (Including Summer & Winter Break)
Generous Benefits Package with a variety of plans available with a substantial employer match
Paid Paternity/Maternity Leave
In-Office Catered lunches
Home Office Setup
Lifestyle Spending Stipend
Commuter Stipend (Boston Office)
Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Company
Kura Oncology, Inc.
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$1.24BKey Investors
Bristol-Myers SquibbHercules CapitalEcoR1 Capital
2024-01-24Post Ipo Equity· $150M
2023-06-14Post Ipo Equity· $100M
2022-11-03Post Ipo Equity· $25M
Recent News
2024-11-23
BioWorld Financial Watch
2024-11-23
Company data provided by crunchbase